Tag
Emcure Pharmaceuticals Limited
2 articles
Emcure Schedules Analyst/Investor Meets May-June 2026
Emcure Pharmaceuticals intimates schedule for participation in multiple analyst and investor conferences from May to June 2026.
Meetings include group and one-on-one sessions at events hosted by Ambit
Emcure Receives 7 US FDA Observations at Sanand Facility
Emcure Pharmaceuticals discloses US FDA inspection results at its Sanand formulations facility from May 6-15, 2026.
The inspection concluded with a Form 483 containing 7 observations, described as pro